{"company":{"id":2533316,"name":"Fate Therapeutics","domain":"fatetherapeutics.com","url":"https://alion.io/company/fatetherapeutics"},"section":"news","answer":"Fate Therapeutics: 40 headlines on record, 25 headlines in the last 90 days. Its story counts 3 milestones.","figures":[{"label":"Headlines","value":"40"},{"label":"In 90 days","value":"25"},{"label":"Milestones","value":"3"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":21},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":3}],"news":[{"date":"2026-10-07","kind":"News","title":"Fate Therapeutics stock adds two Q4 conference dates","source":"Fate Therapeutics stock adds two Q4 conference dates","url":"https://ad-hoc-news.de/boerse/news/nebenwerte/fate-therapeutics-stock-adds-two-q4-conference-dates/70246307"},{"date":"2026-10-06","kind":"News","title":"Fate Therapeutics stock gained 4.74 percent on October 5","source":"Fate Therapeutics stock gained 4.74 percent on October 5","url":"https://ad-hoc-news.de/boerse/news/corporate-news/fate-therapeutics-stock-gained-4-74-percent-on-october-5/70241246"},{"date":"2026-10-01","kind":"Blog","title":"Providence Medical Foundation","url":"https://fatetherapeutics.com/providence-medical-foundation-3/"},{"date":"2026-10-01","kind":"News","title":"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences","source":"markets.businessinsider.com","url":"https://markets.businessinsider.com/news/stocks/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences-1036588960"},{"date":"2026-10-01","kind":"Blog","title":"University of Southern California","url":"https://fatetherapeutics.com/university-of-southern-california/"},{"date":"2026-10-01","kind":"Blog","title":"UC San Diego Moores Cancer Center","url":"https://fatetherapeutics.com/uc-san-diego-moores-cancer-center/"},{"date":"2026-10-01","kind":"Blog","title":"University of Nebraska Medical Center","url":"https://fatetherapeutics.com/university-of-nebraska-medical-center-2/"},{"date":"2026-10-01","kind":"Blog","title":"Miami Dermatology and Laser Research","url":"https://fatetherapeutics.com/miami-dermatology-and-laser-research/"},{"date":"2026-10-01","kind":"Blog","title":"University of Florida Clinical Research Center","url":"https://fatetherapeutics.com/university-of-florida-clinical-research-center/"},{"date":"2026-10-01","kind":"Blog","title":"University of California San Francisco","url":"https://fatetherapeutics.com/university-of-california-san-francisco-2/"},{"date":"2026-10-01","kind":"Blog","title":"University of California Irvine","url":"https://fatetherapeutics.com/university-of-california-irvine-2/"},{"date":"2026-10-01","kind":"Blog","title":"Kaiser Permanente Fontana","url":"https://fatetherapeutics.com/kaiser-permanente-fontana/"},{"date":"2026-10-01","kind":"Blog","title":"The University of Texas Southwestern Medical Center","url":"https://fatetherapeutics.com/the-university-of-texas-southwestern-medical-center/"},{"date":"2026-10-01","kind":"Blog","title":"Cross Creek Medical Clinic","url":"https://fatetherapeutics.com/cross-creek-medical-clinic/"},{"date":"2026-10-01","kind":"Blog","title":"Nicklaus Children's Hospital","url":"https://fatetherapeutics.com/nicklaus-childrens-hospital-2/"},{"date":"2026-10-01","kind":"Blog","title":"Wallace Rheumatic Studies Center","url":"https://fatetherapeutics.com/wallace-rheumatic-studies-center/"},{"date":"2026-09-29","kind":"Blog","title":"Rheumatoid Arthritis (RA)","url":"https://fatetherapeutics.com/rheumatoid-arthritis-ra/"},{"date":"2026-09-28","kind":"News","title":"Fate Therapeutics receives California Institute for Regenerative Medicine $15.0 mn grant through its CLIN2 programme to advance RECLAIM-LN","source":"pharmabiz.com","url":"https://pharmabiz.com/ArticleDetails.aspx?aid=190878&amp;sid=2"},{"date":"2026-09-25","kind":"News","title":"Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/fate-therapeutics-announces-receipt-california-110000885.html"},{"date":"2026-09-21","kind":"Blog","title":"Safety and Efficacy of an Off-the-Shelf Anti-CD19 CAR T-Cell Therapy With Reduced Conditioning in SLE Supporting Same-Day Discharge","url":"https://fatetherapeutics.com/safety-and-efficacy-of-an-off-the-shelf-anti-cd19-car-t-cell-therapy-with-reduced-conditioning-in-sle-supporting-same-day-discharge/"},{"date":"2026-09-21","kind":"Blog","title":"Off-the-Shelf Dual-CAR T-Cell Therapy: Targeting B and T Cells in Autoimmune Disease Without Preconditioning","url":"https://fatetherapeutics.com/off-the-shelf-dual-car-t-cell-therapy-targeting-b-and-t-cells-in-autoimmune-disease-without-preconditioning/"}],"story":[{"title":"Raised a round Venture round $50M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1434316/000143431620000001/"},{"title":"Raised a round Venture round $56.7M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1434316/000143431616000008/"},{"title":"Raised a round Venture round $10.3M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1434316/000143431616000007/"}],"as_of":"2026-11-18","cite":"Fate Therapeutics, News. Alion, Nov 18, 2026. https://alion.io/company/fatetherapeutics/news","html_url":"https://alion.io/company/fatetherapeutics/news","json_url":"https://alion.io/company/fatetherapeutics/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-18T19:45:52Z"}}